Success Metrics

Completion Rate
0%(0/1)
Active Trials
1(33%)
Terminated
1(33%)

Phase Distribution

Ph not_applicable
1
33%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution1 total trials
N/ANon-phased studies
1(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

0.0%

0 of 1 finished

Non-Completion Rate

100.0%

1 ended early

Currently Active

1

trials recruiting

Total Trials

3

all time

Status Distribution
Active(2)
Terminated(1)

Detailed Status

Active, not recruiting1
Enrolling by invitation1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
1
Success Rate
0.0%
Most Advanced
N/A

Trials by Phase

N/A1 (100.0%)

Trials by Status

active_not_recruiting133%
enrolling_by_invitation133%
terminated133%

Recent Activity

1 active trials
Showing 3 of 3
active_not_recruiting

Real-World Experience - Barostim™ Advancing the Level of Clinical Evidence (REBALANCE Registry)

NCT04502316
enrolling_by_invitationnot_applicable

Barostim-Enabled NEurohormonal Intervention For Improving Treatment of Heart Failure

NCT07232030
terminated

Symptomatic CRT Patients: Real-World Experience - Barostim™ Advancing the Level of Clinical Evidence

NCT05860348

Clinical Trials (3)

Showing 3 of 3 trials
NCT04502316

Real-World Experience - Barostim™ Advancing the Level of Clinical Evidence (REBALANCE Registry)

Active Not Recruiting
NCT07232030Not Applicable

Barostim-Enabled NEurohormonal Intervention For Improving Treatment of Heart Failure

Enrolling By Invitation
NCT05860348

Symptomatic CRT Patients: Real-World Experience - Barostim™ Advancing the Level of Clinical Evidence

Terminated

All 3 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
3